[18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.

OriginalsprogEngelsk
TidsskriftP E T Clinics
Vol/bind10
Udgave nummer1
Sider (fra-til)89-104
ISSN1556-8598
DOI
StatusUdgivet - 2015

Fingeraftryk

Fluorodeoxyglucose F18
breast
tomography
cancer
epidemiology
Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
planning
radiation therapy
Neoplasms
Epidemiology
evaluation

Emneord

  • Breast Neoplasms/di [Diagnosis] computer assisted tomography *diagnostic use female Genital Neoplasms, Female/di [Diagnosis] human multimodal imaging positron emission tomography *procedures fluorodeoxyglucose f 18 radiopharmaceutical agent

Citer dette

@article{78af712433cf4b06a1d016d1ed13c8d8,
title = "[18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review",
abstract = "In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.",
keywords = "Breast Neoplasms/di [Diagnosis] computer assisted tomography *diagnostic use female Genital Neoplasms, Female/di [Diagnosis] human multimodal imaging positron emission tomography *procedures fluorodeoxyglucose f 18 radiopharmaceutical agent",
author = "Hildebrandt, {Malene Grubbe} and Kodahl, {Annette Raskov} and Dorte Teilmann-J{\o}rgensen and Ole Mogensen and Jensen, {Pernille Tine}",
note = "Copyright {\circledC} 2015 Elsevier Inc. All rights reserved.",
year = "2015",
doi = "10.1016/j.cpet.2014.09.007",
language = "English",
volume = "10",
pages = "89--104",
journal = "P E T Clinics",
issn = "1556-8598",
publisher = "W.B.Saunders Co.",
number = "1",

}

[18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers : a literature review. / Hildebrandt, Malene Grubbe; Kodahl, Annette Raskov; Teilmann-Jørgensen, Dorte; Mogensen, Ole; Jensen, Pernille Tine.

I: P E T Clinics, Bind 10, Nr. 1, 2015, s. 89-104.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - [18F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers

T2 - a literature review

AU - Hildebrandt, Malene Grubbe

AU - Kodahl, Annette Raskov

AU - Teilmann-Jørgensen, Dorte

AU - Mogensen, Ole

AU - Jensen, Pernille Tine

N1 - Copyright © 2015 Elsevier Inc. All rights reserved.

PY - 2015

Y1 - 2015

N2 - In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.

AB - In this literature review, an update is provided on the role of [(18)F]fluorodeoxyglucose PET/computed tomography in different clinical settings of the 4 most frequent female-specific cancer types: breast, endometrial, ovarian, and cervical cancer. The most recent knowledge regarding primary diagnosis, staging, response evaluation, prognostic and predictive values, recurrence detection, and radiotherapy planning is evaluated, including, when clinically relevant, considerations with respect to the epidemiology, treatment, and course of the diseases.

KW - Breast Neoplasms/di [Diagnosis] computer assisted tomography diagnostic use female Genital Neoplasms, Female/di [Diagnosis] human multimodal imaging positron emission tomography procedures fluorodeoxyglucose f 18 radiopharmaceutical agent

U2 - 10.1016/j.cpet.2014.09.007

DO - 10.1016/j.cpet.2014.09.007

M3 - Review

C2 - 25455882

VL - 10

SP - 89

EP - 104

JO - P E T Clinics

JF - P E T Clinics

SN - 1556-8598

IS - 1

ER -